Federal Supply Schedule 36F79725D0201
Award Date
8/1/25
Last Date to Order
7/31/30
Federal Agency
Veterans Integrated Service Network 12
Awardee
Syndax Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Axsome Therapeutics Inc., provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The $25,000 contract has a period of performance through February 28, 2023. As a multiple award FSS, this contract allows for orders to be placed by any federal agency. The contract does not utilize any set-asides. This interim agreement under the FSS facilitates the...
The federal contract IDV award described is a Federal Supply Schedule (FSS) contract under Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products, awarded to Syndax Pharmaceuticals, Inc. by the Department of Veterans Affairs. The contract has a ceiling value of $25,000.00 and a period of performance from February 1, 2025 to July 31, 2025. The contract aims to procure various pharmaceutical products and hematology-related supplies for the Veterans Integrated Service Network 12....
This Federal Supply Schedule (FSS) contract award, Contract ID 36F79724D0187, was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a total ceiling value of $250,000.00 and will run through August 31, 2029. The purpose of this multiple-award FSS contract is to procure Drugs, Pharmaceuticals, and Hematology Related Products (FSC 65 I B) from the prime contractor, Sentynl Therapeutics, Inc. The...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA) to Alnylam Pharmaceuticals, Inc., covers the procurement of pharmaceutical and hematology-related products under FSS-61-IB. The contract has a ceiling value of $4,149,600.00 and a period of performance from February 1, 2019 to March 1, 2026. As a multiple award FSS contract, it provides a mechanism for the VA and other federal agencies to purchase a variety of pharmaceutical and drug products...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to NS Pharma, Inc., a foreign-owned for-profit manufacturer of pharmaceutical and hematology-related products. The contract, with a ceiling value of $225,000, has an ultimate completion date of March 14, 2026 and was originally awarded on March 15, 2021. The scope of the contract includes the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the GSA Schedule...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to Ascend Therapeutics US LLC, a foreign-owned for-profit organization. The $25,000 interim agreement is under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, with a period of performance through September 14, 2023. As a multiple award contract, this FSS provides the VA with a pre-negotiated list of products and services that can be ordered as needed. The scope of...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to EMD Serono Inc. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and has a ceiling value of $271,515,660.00. The period of performance runs from the award date of April 15, 2018 through April 14, 2025. The contract is intended to procure a wide range of pharmaceutical and hematology-related products for the Department of...
The Federal Supply Schedule (FSS) contract award, with ID 36F79723D0229, was granted to Legacy Pharma USA, Inc., a foreign-owned, self-certified small disadvantaged business, for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This multiple-award contract has a ceiling value of $6,150,000.00 and a period of performance ending on September 14, 2028. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department...
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Enzyvant Therapeutics Inc. The contract is for pharmaceutical and hematology-related products under Schedule 65 I B of the FSS program. The contract has a ceiling value of $25,000.00 and a period of performance from January 1, 2023 to June 30, 2023. As an FSS contract, this is a multiple award vehicle allowing other federal agencies to place orders against the schedule. The contract was awarded...
This Federal Supply Schedule contract was awarded to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business, by the Department of Veterans Affairs' Veterans Integrated Service Network 12. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B schedule. While the specific products and services were not detailed...